Valuation Valneva SE

Stocks

Market Closed - Euronext Paris 11:55:00 2026-10-05 EDT			After hours 14:58:11
2.553 ^EUR	+0.87%		2.580	+1.06%

08-14	Pfizer and Valneva Se Announce European Medicines Agency Validation of Marketing Authorization Application for Lyme Disease Vaccine Candidate	CI
08-14	Pfizer Inc. and Valneva Se Enter Strategic Alliance for Co-Development of Lyme Disease Vaccine Candidate	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,574	861.1	655.1	351.1	642.3	480	-	-
Change	-	-66.55%	-23.93%	-46.4%	82.94%	-25.27%	-	-
Enterprise Value (EV) ¹	2,286	670.5	737.8	399.1	739.9	613.7	542.5	531.7
Change	-	-70.66%	10.04%	-45.9%	85.38%	-17.06%	-11.61%	-1.99%
P/E	-32.7x	-5.02x	-6.47x	-27x	-5.47x	-5.81x	9.16x	12.1x
PBR	15.1x	-	5.1x	1.94x	6.07x	8.95x	3.76x	2.77x
PEG	-	-0.1x	0.2x	0.3x	-0x	0.2x	-0x	-0.5x
Capitalization / Revenue	7.4x	2.38x	4.26x	2.07x	3.68x	3.18x	1.69x	1.93x
EV / Revenue	6.57x	1.86x	4.8x	2.35x	4.24x	4.06x	1.91x	2.14x
EV / EBITDA	-48.5x	-9.69x	-11.3x	12.1x	-12.5x	-18.3x	5.23x	9.9x
EV / EBIT	-37.2x	-5.91x	-8.99x	29.9x	-9.12x	-10.6x	7.02x	9.92x
EV / FCF	-140x	-2.44x	-3.4x	-4.92x	-12.9x	-13.1x	5.91x	69.7x
FCF Yield	-0.71%	-41%	-29.4%	-20.3%	-7.75%	-7.65%	16.9%	1.44%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.75	-1.24	-0.73	-0.08	-0.68	-0.4357	0.2762	0.2083
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	348.1	361.3	153.7	169.6	174.7	151	283.4	248.4
EBITDA ¹	-47.1	-69.2	-65.24	32.92	-59.42	-33.62	103.7	53.7
EBIT ¹	-61.4	-113.4	-82.09	13.33	-81.16	-57.79	77.25	53.6
Net income ¹	-73.4	-143.3	-101.4	-12.25	-115.2	-81.11	53.07	28.74
Net Debt ¹	-288.9	-190.6	82.74	48.04	97.6	133.7	62.48	51.7
Reference price ²	24.500	6.224	4.720	2.162	3.718	2.531	2.531	2.531
Nbr of stocks (in thousands)	105,078	138,355	138,788	162,397	172,759	189,647	-	-
Announcement Date	2/3/22	3/23/23	3/21/24	3/20/25	3/17/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VALNEVA SE	-5.81x	4.06x	-18.25x	-	540M
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	18.30x	28.64x	9.40x	0.31%	39.11B
Weighted average by Cap.	22.23x	32.00x	13.51x	0.42%